Skip to main content

ETF comparison

VHT vs XBI

Both Healthcare.

Vanguard Health Care Index Fund ETF Shares · State Street SPDR S&P Biotech ETF

Holdings overlap

Weighted by ISIN/CUSIP
13.3 %

134 positions appear in both funds. Buying equal dollars of VHT and XBI would leave roughly 13.3% of each dollar exposed to the same underlying securities.

VHT unmatched 86.5% Shared 13.3% XBI unmatched 86.7%

Unmatched is the part of a fund's weight the other fund doesn't match: names only it holds, plus any extra weight it puts in names both funds hold.

In VHT only
279 positions
Shared
134 positions
In XBI only
22 positions

Side by side

VHT

Vanguard Health Care Index Fund ETF Shares

Vanguard · Healthcare

84 composite / 100
Expense ratio
0.090%
Net assets
$23.73B
whole fund, 2 share classes
TTM yield
1.32%
Top-10 conc.
51.7%
XBI

State Street SPDR S&P Biotech ETF

State Street · Healthcare

82 composite / 100
Expense ratio
0.35%
Net assets
$10.92B
TTM yield
0.35%
Top-10 conc.
13.3%

Sub-score comparison

91
Cost
65
83
Tax efficiency
85
100
Liquidity
100
40
Concentration
95
—
Tracking quality
—
VHT sub-score XBI

Tracking quality isn't part of the composite — see what we don't score for why.

Cost difference

VHT is 26 bps cheaper than XBI. On a $100,000 position that's about $260/yr more in fees for XBI.

Fee figure is the annual expense charged on $100,000. To see how the gap compounds over a multi-decade holding period, open the cost calculator pre-filled with VHT vs XBI.

Top shared holdings

134 shared in total
# Holding In VHT In XBI Overlap
1 Vertex Pharmaceuticals Inc 1.92% 1.06% 1.06%
2 AbbVie Inc 6.28% 1.04% 1.04%
3 Amgen Inc 3.21% 0.99% 0.99%
4 Gilead Sciences Inc 2.52% 0.96% 0.96%
5 Regeneron Pharmaceuticals Inc 1.15% 0.96% 0.96%
6 Natera Inc 0.60% 1.16% 0.60%
7 Moderna Inc 0.56% 1.41% 0.56%
8 REVOLUTION Medicines Inc 0.46% 1.20% 0.46%
9 Alnylam Pharmaceuticals Inc 0.44% 0.96% 0.44%
10 Biogen Inc 0.44% 1.03% 0.44%
11 Insmed Inc 0.36% 1.08% 0.36%
12 Incyte Corp 0.29% 1.00% 0.29%

Only in VHT

279 total
  • Eli Lilly & Co 12.87%
  • Johnson & Johnson 8.75%
  • Merck & Co Inc 5.06%
  • UnitedHealth Group Inc 4.90%
  • Thermo Fisher Scientific Inc 3.18%
  • Abbott Laboratories 2.66%
  • Pfizer Inc 2.24%
  • Bristol-Myers Squibb Co 1.89%
  • Danaher Corp 1.88%
  • Intuitive Surgical Inc 1.85%

Only in XBI

22 total
  • CRISPR Therapeutics AG 1.02%
  • Nuvalent Inc 0.93%
  • Catalyst Pharmaceuticals Inc 0.87%
  • Absci Corp 0.56%
  • Hyperliquid Strategies Inc 0.46%
  • Avalo Therapeutics Inc 0.35%
  • Immix Biopharma Inc 0.20%
  • Candel Therapeutics Inc 0.19%
  • Damora Therapeutics Inc 0.17%
  • Cabaletta Bio Inc 0.15%

Percentages are holdings overlap with the named fund.

Open VHT or XBI at a brokerage

Both funds trade commission-free at major US brokerages.

Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodology and funding disclosure.

Holdings overlap is the sum of min(weight_a, weight_b) over positions matched on ISIN (CUSIP fallback). Methodology: see /methodology/.

Comparing two funds doesn't endorse swapping one for the other. Tax-lot history, account type, and personal goals matter — PlainIndex publishes data and methodology, not investment advice.